Cigna Investments Inc. New Acquires New Position in UBS AG (NYSE:UBS)
Cigna Investments Inc. New acquired a new stake in shares of UBS AG (NYSE:UBS) during the second quarter, Holdings Channel reports. The fund acquired 71,012 shares of the bank’s stock, valued at approximately $1,204,000.
Several other hedge funds also recently made changes to their positions in UBS. Advisors Asset Management Inc. bought a new stake in shares of UBS AG during the first quarter valued at about $490,000. Caisse DE Depot ET Placement DU Quebec boosted its stake in shares of UBS AG by 0.4% in the first quarter. Caisse DE Depot ET Placement DU Quebec now owns 833,317 shares of the bank’s stock valued at $13,360,000 after buying an additional 3,318 shares during the last quarter. Trexquant Investment LP boosted its stake in shares of UBS AG by 73.7% in the first quarter. Trexquant Investment LP now owns 58,884 shares of the bank’s stock valued at $939,000 after buying an additional 24,984 shares during the last quarter. Fox Run Management L.L.C. bought a new stake in shares of UBS AG during the second quarter valued at about $292,000. Finally, Morgan Stanley boosted its stake in shares of UBS AG by 78.8% in the first quarter. Morgan Stanley now owns 2,888,708 shares of the bank’s stock valued at $46,076,000 after buying an additional 1,272,696 shares during the last quarter. Institutional investors and hedge funds own 26.32% of the company’s stock.
UBS AG (UBS) opened at 17.31 on Thursday. UBS AG has a one year low of $12.86 and a one year high of $18.31. The stock has a market cap of $64.33 billion, a price-to-earnings ratio of 16.30 and a beta of 1.24. The firm’s 50 day moving average price is $17.35 and its 200 day moving average price is $16.40.
COPYRIGHT VIOLATION NOTICE: This news story was originally published by Watch List News and is owned by of Watch List News. If you are accessing this news story on another domain, it was illegally stolen and republished in violation of US & international trademark & copyright legislation. The correct version of this news story can be accessed at https://www.watchlistnews.com/cigna-investments-inc-new-acquires-new-position-in-ubs-ag-nyseubs/1469367.html.
UBS has been the topic of several analyst reports. J P Morgan Chase & Co upgraded UBS AG from a “neutral” rating to an “overweight” rating in a research note on Monday, June 26th. Zacks Investment Research upgraded UBS AG from a “sell” rating to a “hold” rating and set a $19.00 price objective on the stock in a research note on Wednesday, May 10th. BidaskClub lowered UBS AG from a “hold” rating to a “sell” rating in a report on Thursday, August 3rd. Rafferty Capital Markets lowered UBS AG from a “buy” rating to a “hold” rating in a report on Saturday, April 22nd. Finally, Morgan Stanley reissued a “buy” rating on shares of UBS AG in a report on Tuesday, July 18th. Two investment analysts have rated the stock with a sell rating, five have given a hold rating and seven have assigned a buy rating to the company. The company currently has an average rating of “Hold” and an average price target of $17.14.
UBS AG Company Profile
UBS Group AG is a holding company and conducts its operations through UBS AG and its subsidiaries. The Company comprises Corporate Center and five business divisions: Wealth Management, Wealth Management Americas, Personal & Corporate Banking, Asset Management and the Investment Bank. Wealth Management division provides advice and tailored financial services to wealthy private clients around the world, except those served by Wealth Management Americas.
Want to see what other hedge funds are holding UBS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UBS AG (NYSE:UBS).
Receive News & Ratings for UBS AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UBS AG and related companies with Analyst Ratings Network's FREE daily email newsletter.